Private insurers currently play differing roles in European national healthcare systems

Bharatbook added a new report on “The Private Health Insurance Market in Europe: Future trends, emerging opportunities and key players” which gives the European private insurance industry, including overall trends and profiles of leading insurers.
 
 The Private Health Insurance Market in Europe: Future trends, emerging opportunities and key players
 
 The dynamics of healthcare funding in Europe is changing. As governments review their options to meet growing healthcare demands with limited resources, the potential to combine cost reduction with new funding sources will gain support in many countries. Reimbursement decisions in the public sector are becoming increasingly tougher for pharmaceutical and diagnostic manufacturers; the private market offers a potential alternative route to gaining market access. ( http://www.bharatbook.com/detail.asp?id=141581&rt=The-Private-Health-Insurance-Market-in-Europe-Future-trends-emerging-opportunities-and-key-players.html )
 
 Private insurers currently play differing roles in European national healthcare systems. This report reviews their role in the major European markets and provides an insight into trends in their coverage of health benefits and products. It highlights selected product areas where private insurance could fill the gaps in public reimbursement . An insight into the European private insurance industry, including overall trends and profiles of leading insurers, provides an indication of future developments within the sector and highlights potential opportunities for pharmaceutical and diagnostic companies to work with private insurers.
 
 Key features of this report
 
 * Reviews healthcare systems and the role of private insurers in the five major European markets of France, Germany, Italy, Spain and the UK.
 * Analyzes the healthcare systems in the Netherlands and Switzerland, where mandatory health insurance is purchased from private insurers operating in regulated competitive models. These have parallels with the State of Massachusetts’ system, which has been considered a blueprint for other US states and for federal reform.
 * Examines some of the issues in gaining market access for pharmaceuticals and diagnostics through coverage by private health insurers and highlights initiatives being undertaken by insurers that present potential partnership opportunities for companies.
 * Details trends in the private health insurance market, including relative market shares for the main markets in terms of benefits paid for by private insurers.
 
 Scope of this report
 
 * Understand the diverse roles played by private insurance in funding pharmaceutical and diagnostic products in major European markets and the relative importance of private funds in healthcare spending.
 * Identify the key players in each market who will be potential targets for gaining market access in the privately-funded sector.
 * Review what new opportunities might be afforded in the private sector for products that are denied reimbursement in the public sector.
 * Tailor product portfolios to meet differing needs of individual markets.
 
 To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/detail.asp?id=141581&rt=The-Private-Health-Insurance-Market-in-Europe-Future-trends-emerging-opportunities-and-key-players.html  
 
 Related Report :
 
 Affinity and Partnership Marketing in Accident and Health Insurance in Germany
 http://www.bharatbook.com/detail.asp?id=101494&rt=Affinity-and-Partnership-Marketing-in-Accident-and-Health-Insurance-in-Germany.html
 
 Affinity and Partnership Marketing in UK Accident and Health Insurance
 http://www.bharatbook.com/detail.asp?id=101303&rt=Affinity-and-Partnership-Marketing-in-UK-Accident-and-Health-Insurance.html
 
 
Or
 
 Contact us at :
 
 Bharat Book Bureau
 Tel: +91 22 27578668
 Fax: +91 22 27579131
 Email: info@bharatbook.com
 Website: www.bharatbook.com
 Follow us on twitter: http://twitter.com/3bbharatbook

Also on Private insurers currently play differing roles in European national healthcare systems